Grifols (GRFS) Sales of Property, Plant and Equipment (2010 - 2016)

Grifols (GRFS) Sales of Property, Plant and Equipment (2010 - 2016) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn 36.40 Mn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn -
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 29.00 Mn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn -
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn -
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn -
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn -
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn -
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn -
10 Grifols 5.85 Bn 4.89 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2016 336,873.96
Dec 31, 2016 336,873.96
Sep 30, 2016 401,826.41
Sep 30, 2016 401,826.41
Dec 31, 2015 174,282.65
Dec 31, 2015 174,282.65
Sep 30, 2015 104,554.78
Sep 30, 2015 104,554.78
Jun 30, 2015 765,862.90
Jun 30, 2015 765,862.90
Mar 31, 2015 15.10 Mn
Mar 31, 2015 15.10 Mn
Mar 31, 2013 7.82 Mn
Mar 31, 2013 7.82 Mn
Dec 31, 2012 -372.09 Mn
Dec 31, 2012 -372.09 Mn
Sep 30, 2012 52.79 Mn
Sep 30, 2012 52.79 Mn
Jun 30, 2012 100.95 Mn
Jun 30, 2012 100.95 Mn